In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
The in vitro activities of rufloxacin and its metabolite, MF 922, were compared with those of ofloxacin, ciprofloxacin, erythromycin, and minocycline against Mycoplasma pneumoniae, Mycoplasma hominis, Mycoplasma fermentans, and Ureaplasma urealyticum. Rufloxacin, MF 922, and ciprofloxacin shared similar activities against all mycoplasmas tested. (MICs for 90% of isolates tested [MIC90s], 0.5 to 4 micrograms/ml. Ofloxacin had the lowest MIC90s for U. urealyticum, M. fermentans, and M. hominis (MIC90s, 0.25 to 1 micrograms/ml) and erythromycin had the lowest MIC90 for M. pneumoniae (MIC90, 0.004 micrograms/ml).
Furneri
P M
PM
Institute of Microbiology, University of Catania, Italy.
Bisignano
G
G
Cerniglia
G
G
Nicoletti
G
G
Cesana
M
M
Tempera
G
G
D000890:Anti-Infective Agents / Q000378:metabolism / Q000494:pharmacology*; D024841:Fluoroquinolones; D008826:Microbial Sensitivity Tests; D009174:Mycoplasma / Q000187:drug effects*; D015363:Quinolones / Q000378:metabolism / Q000494:pharmacology*; D013843:Thiazines / Q000494:pharmacology*; D016990:Ureaplasma urealyticum / Q000187:drug effects*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D013843:Thiazines; C074116:N-desmethylrufloxacin; C060328:rufloxacin